The following biotech stocks that were featured on our site recently touched new highs yesterday. Did you capitalize on their upward momentum?
Ticker
Published Date
Published Price
Maximum Price Since Publication
*Last Closing Price
Maximum Gain %
Olema Pharmaceuticals Inc. (OLMA)
Oct.13, 2022
$2.96
$11.15
$10.60
276%
ANI Pharmaceuticals Inc. (ANIP)
May 8, 2023
$42.58
$63.10
$61.08
48%
Phathom Pharmaceuticals Inc. (PHAT)
Jul.10, 2023
$13.98
$16.14
$15.13
15%
Amphastar Pharmaceuticals Inc. (AMPH)
Mar.6, 2023
$35.13
$67.66
$62.21
92%
EyePoint Pharmaceuticals Inc. (EYPT)
Aug.1, 2023
$12.70
$13.46
$13.13
6%
Stevanato Group S.p.A. (STVN)
Feb.24, 2023
$21.36
$36.30
$33.97
70%
InfuSystem Holdings Inc. (INFU)
Feb.6, 2023
$10.47
$11.26
$11.24
7%
Medpace Holdings Inc. (MEDP)
Apr.25, 2023
$208.27
$267.13
$265.47
28%
Reata Pharmaceuticals Inc. (RETA)
Mar.1, 2023
$93.17
$168.70
$167.11
81%
MannKind Corp. (MNKD)
Nov.21, 2022
$4.30
$5.75
$5.34
33%
Tango Therapeutics, Inc. (TNGX)
Jun.13, 2023
$3.63
$9.39
$7.81
158%
(*Last Closing Price refers to the closing price of the stock on Aug.9, 2023)
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.